z-logo
open-access-imgOpen Access
Antigenemia, RNA emia, and innate immunity in children with acute rotavirus diarrhea
Author(s) -
Moon Sungsil,
Wang Yuhuan,
Dennehy Penelope,
Simonsen Kari A.,
Zhang John,
Jiang Baoming
Publication year - 2012
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.2011.00923.x
Subject(s) - rotavirus , viremia , peripheral blood mononuclear cell , diarrhea , immunology , virology , acute diarrhea , biology , antigen , medicine , virus , in vitro , biochemistry
Antigenemia is commonly detected in children with acute rotavirus diarrhea, but the prevalence of viremia has not been clearly defined. We examined antigenemia in plasma and RNA emia in peripheral blood mononuclear cells ( PBMC ) of children with acute diarrhea by EIA , RT ‐ PCR , and S outhern hybridization, using primers and a probe specific to rotavirus NSP 4 gene. We detected the presence of rotavirus antigen in 33.3% and almost full‐length NSP 4 gene in 70.8% of the acute‐phase plasma and PBMC , respectively. In contrast, antigenemia and RNA emia were detected in 0% and 4.2% of the convalescent‐phase plasma and PBMC , respectively, which were similar to antigenemia (0%) and RNA emia (7.7%) in healthy controls. We demonstrated an increase in the proportions of activated myeloid dendritic cells ( mDC ) and activated plasmacytoid DC ( pDC ) in acute‐phase PBMC of patients when compared to those in convalescent phase of patients and in PBMC of healthy controls. The activation of mDC peaked on days 2–4 after illness onset, and the activation of acute‐phase pDC appeared to correlate with levels of antigenemia. High prevalence of NSP 4 gene in acute‐phase PBMC indicates possible rotavirus replication in white blood cells, and extraintestinal spread and the activation of DC may have implications for the prevention of rotavirus disease in children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here